Lupus Clinical Trials
Overcome Challenges to Data Quality, Patient Eligibility and Placebo Responses with An Experienced Partner
There are promising therapies on the horizon for lupus patients, but to get these to the market, you must effectively plan for unique challenges to data quality, patient eligibility, placebo responses and efficacy signal detection rates. Choosing the right CRO partner is essential to support and deliver your lupus therapy to the patients who need them.
From PPD’s strong immunology and rheumatology teams, we bring deep strength, experience and reach in lupus. Not only do we have leading operational and medical experience, we have partnerships that enhance data quality and provide our clients with near real-time access to lupus endpoint data.